EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Ultrasound, PET/CT or temporal artery biopsy for giant cell arteritis? A prospective diagnostic accuracy study (the GAME‐study)

Michael S Hansen iD, Lene Terslev iD, Uffe M Døhn iD, Viktoria Fana iD, Jane M Brittain iD, Anne K Wiencke iD, Steffen Heegaard iD, Mads R Jensen, Oliver N Klefter iD, Yousif Subhi iD, Steffen Hamann iD

Acta Ophthalmologica · 2026

DOI: 10.1111/aos.70114 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Ophthalmologica, 2026. Verfasst von Michael S Hansen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Positron Emission Tomography Computed Tomography, Temporal Arteries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gigtforeningen (The Danish Rheumatism Association), Synoptik-Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the diagnostic performance of ultrasound, 2‐deoxy‐2‐[ 18 F]fluoro‐D‐glucose positron emission tomography/computed tomography (2‐[ 18 F]FDG PET/CT) and temporal artery biopsy (TAB) in giant cell arteritis (GCA).

Methods

This was a prospective single‐centre diagnostic accuracy study ( ClinicalTrials.gov NCT05248906). One hundred and ten patients suspected of GCA were considered, of which 103 were analysed, 100 had a final diagnosis and 58 had complete data for all modalities. Ultrasound, 2‐[ 18 F]FDG PET/CT and TAB were performed after clinical examination and blood sampling. The main outcome included diagnostic accuracy measures with final clinical expert diagnosis at 6‐month follow‐up as the comparator.

Results

Sixty‐one patients had GCA, 39 had non‐GCA and 3 had inconclusive. The sensitivities were 82% (95% CI: 66%–92%), 74% (95% CI: 57%–87%) and 68% (95% CI: 51%–83%) for ultrasound, 2‐[ 18 F]FDG PET/CT and TAB, respectively. The corresponding specificities were 90% (95% CI: 68%–99%), 100% (95% CI: 83%–100%) and 100% (95% CI: 83%–100%), the positive predictive values 94% (95% CI: 81%–98%), 100% (95% CI: 88%–100%) and 100% (95% CI: 87%–100%), the negative predictive values 72% (95% CI: 57%–84%), 67% (95% CI: 54%–77%) and 63% (95% CI: 51%–73%) and accuracies 85% (95% CI: 73%–93%), 83% (95% CI: 71%–91%) and 79% (95% CI: 67%–89%). When ultrasound was inconclusive, 2‐[ 18 F]FDG PET/CT had a higher sensitivity of 75% (95% CI: 35%–97%) vs. 38% (95% CI: 9%–76%) for TAB, with equal specificity of 100% (both 95% CI: 69%–100%). Results were inconclusive in 22 of 99 ultrasounds, 3 of 102 2‐[ 18 F]FDG PET/CTs and 4 of 90 TABs.

Conclusion

Ultrasound had high diagnostic accuracy for GCA, supporting this as the first imaging modality in suspected GCA. 2‐[ 18 F]FDG PET/CT combined a high diagnostic accuracy with fewer inconclusive results, suggesting it may be used for second‐line testing when ultrasound is inconclusive, reserving TAB for third‐line testing. A fast‐track setup may facilitate efficient diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell ArteritisPositron Emission Tomography Computed TomographyTemporal ArteriesAgedAged, 80 and overFemaleHumansMaleMiddle AgedBiopsyFluorodeoxyglucose F18Follow-Up StudiesProspective StudiesRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityUltrasonography

Stichwörter der Autor:innen

2‐[18F]FDG PET/CTGiant cell arteritisparacentral acute middle maculopathytemporal artery biopsyultrasound

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Ophthalmology, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Department of Pathology, Eye Pathology Section, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Physiology and Nuclear Medicine, Bispebjerg Hospital, Copenhagen, Denmark.

ORCID-Profile: Michael S Hansen, Lene Terslev, Uffe M Døhn, Viktoria Fana, Jane M Brittain, Anne K Wiencke, Steffen Heegaard, Oliver N Klefter, Yousif Subhi, Steffen Hamann

Förderung

  • Gigtforeningen (The Danish Rheumatism Association)
  • Synoptik-Fonden

Zitieren

APA

Hansen, M. S., Terslev, L., Døhn, U. M., Fana, V., Brittain, J. M., Wiencke, A. K., Heegaard, S., Jensen, M. R., Klefter, O. N., Subhi, Y., & Hamann, S. (2026). Ultrasound, PET/CT or temporal artery biopsy for giant cell arteritis? A prospective diagnostic accuracy study (the GAME‐study). Acta Ophthalmologica. https://doi.org/10.1111/aos.70114

Vancouver

Hansen MS, Terslev L, Døhn UM, Fana V, Brittain JM, Wiencke AK, et al. Ultrasound, PET/CT or temporal artery biopsy for giant cell arteritis? A prospective diagnostic accuracy study (the GAME‐study). Acta Ophthalmologica. 2026. doi:10.1111/aos.70114

BibTeX
@article{Hansen2026,
  author = {Hansen, Michael S and Terslev, Lene and Døhn, Uffe M and Fana, Viktoria and Brittain, Jane M and Wiencke, Anne K and Heegaard, Steffen and Jensen, Mads R and Klefter, Oliver N and Subhi, Yousif and Hamann, Steffen},
  title = {Ultrasound, PET/CT or temporal artery biopsy for giant cell arteritis? A prospective diagnostic accuracy study (the GAME‐study)},
  journal = {Acta Ophthalmologica},
  year = {2026},
  doi = {10.1111/aos.70114}
}
Kostenlos starten →